Among them, two demonstrated a transient anti-glioblastoma response, marked by a notable reduction in IL13Rα2 expression in tumor cells, increased tumor necrosis volume observed on MRI scans, and the presence of T cells in tumor microfoci. Here, IL13RA2 is linked to glioblastoma.